Skip to content

CareTrust CTRE Net Change in Cash

Net Change in Cash at other companies

Akamai Technologies logo
Akamai TechnologiesAKAM
-$304.37M-152%
Biogen logo
BiogenBIIB
$392.2M+108%
UDR logo
UDRUDR
-$2.13M-1.3%
Vertiv Holdings Co logo
Vertiv Holdings CoVRT
$401.4M+64.6%
Henry Schein logo
Henry ScheinHSIC
-$18M-460%
Keysight Technologies logo
Keysight TechnologiesKEYS
$235M-77.8%

Other financials

Income statement

See full
Revenue$142.8M+47.8%
Gross profit$49.7M
Net income$80.2M+21.9%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$223.2M-64.7%
Total debt$894.6M+8.8%
Total equity$4.1B+41.1%
Total assets$5.2B+34.8%

Cash flow

See full
Operating cash flow$90.4M+26.6%
CapEx$440.3K
Free cash flow$98.1M+60.6%

Valuation

See full
Market cap$8.76B+52.5%
Enterprise value$9.43B+59.4%
P/E26.1×-9.3×
P/S16.8×-0.6×

Profitability

See full
Gross margin100%
Net margin64.1%+14.9pp
FCF margin82.3%-0.1pp

Returns & leverage

See full
Return on equity9.5%+2.4pp
Debt / equity0.2×-0.1×

Where this comes from

Reported directly by CareTrust in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: CareTrust’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareTrust's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareTrust's net change in cash?
CareTrust (CTRE) reported net change in cash of $25.17M in Q1 2026.
How has CareTrust's net change in cash changed year-over-year?
CareTrust's net change in cash decreased by 94.0% year-over-year, from $418.69M to $25.17M.
What is the long-term trend for CareTrust's net change in cash?
Over 3 years (2021 to 2025), CareTrust's net change in cash has grown at a 152.9% compound annual growth rate (CAGR), from $976K to -$15.78M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.